Immuno-Oncology

The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.

Latest News

Study Finds Link Between Tumor Microbiome and Immunotherapy Outcomes in Soft Tissue Sarcoma
Study Finds Link Between Tumor Microbiome and Immunotherapy Outcomes in Soft Tissue Sarcoma

February 3rd 2023

The study suggests there is measurable amount of microbiome within the soft tissue sarcoma tumor environment, which was previously thought to be sterile.

"Persistent" Subset of Tumor Mutations May Predict Immunotherapy Response
"Persistent" Subset of Tumor Mutations May Predict Immunotherapy Response

January 26th 2023

Axi-cel Shows Improved Quality-Adjusted Survival Versus Standard of Care in LBCL
Axi-cel Shows Improved Quality-Adjusted Survival Versus Standard of Care in LBCL

January 19th 2023

From Lymphomas to Myeloma, Bispecific Antibodies Make a Big Splash at ASH
From Lymphomas to Myeloma, Bispecific Antibodies Make a Big Splash at ASH

January 14th 2023

Immune Profiling Study Offers Potential New Patient-Stratification Tools in Glioblastoma
Immune Profiling Study Offers Potential New Patient-Stratification Tools in Glioblastoma

January 10th 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.